TR199701536T1 - Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�. - Google Patents

Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.

Info

Publication number
TR199701536T1
TR199701536T1 TR97/01536T TR9701536T TR199701536T1 TR 199701536 T1 TR199701536 T1 TR 199701536T1 TR 97/01536 T TR97/01536 T TR 97/01536T TR 9701536 T TR9701536 T TR 9701536T TR 199701536 T1 TR199701536 T1 TR 199701536T1
Authority
TR
Turkey
Prior art keywords
leukemia
treatment
benzimidazoles
drug
manufacture
Prior art date
Application number
TR97/01536T
Other languages
English (en)
Turkish (tr)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199701536T1 publication Critical patent/TR199701536T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
TR97/01536T 1995-06-07 1996-05-22 Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�. TR199701536T1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
TR199701536T1 true TR199701536T1 (xx) 1998-02-21

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01536T TR199701536T1 (xx) 1995-06-07 1996-05-22 Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.

Country Status (17)

Country Link
EP (1) EP0831816A1 (es)
JP (1) JPH11506732A (es)
KR (1) KR19990022617A (es)
CN (1) CN1186433A (es)
AR (1) AR003137A1 (es)
AU (1) AU717382B2 (es)
BR (1) BR9608730A (es)
CA (1) CA2223435A1 (es)
CZ (1) CZ391197A3 (es)
HU (1) HUP9802634A3 (es)
IL (1) IL118424A0 (es)
NO (1) NO975660L (es)
PL (1) PL324026A1 (es)
SK (1) SK168697A3 (es)
TR (1) TR199701536T1 (es)
WO (1) WO1996040122A1 (es)
ZA (1) ZA964373B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (es) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants

Also Published As

Publication number Publication date
NO975660D0 (no) 1997-12-05
JPH11506732A (ja) 1999-06-15
AR003137A1 (es) 1998-07-08
AU5802096A (en) 1996-12-30
PL324026A1 (en) 1998-05-11
IL118424A0 (en) 1996-09-12
EP0831816A1 (en) 1998-04-01
WO1996040122A1 (en) 1996-12-19
NO975660L (no) 1998-02-09
AU717382B2 (en) 2000-03-23
KR19990022617A (ko) 1999-03-25
SK168697A3 (en) 1998-12-02
CA2223435A1 (en) 1996-12-19
CZ391197A3 (cs) 1998-05-13
HUP9802634A2 (hu) 1999-03-29
ZA964373B (en) 1996-09-02
HUP9802634A3 (en) 1999-05-28
CN1186433A (zh) 1998-07-01
BR9608730A (pt) 1999-06-29

Similar Documents

Publication Publication Date Title
TR199701536T1 (xx) Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.
TR199701535T1 (xx) Bis-1,2,4- triazolleri, kanserlerin tedavisi i�in bir ila� �retilmesinde kullan�m�.
TR200002860T2 (tr) Bir antiviral benzimidazol terkibin yeni kristal formları.
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
TR199903053T2 (xx) Benzimidazol t�revleri.
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
BRPI0407305A (pt) Ligantes do receptor de canabinóides e seus usos
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
DE59903765D1 (de) Benzimidazole, deren herstellung und deren verwendung als arzneimittel
TR200100047T2 (tr) Tiyobenzimidazol türevleri
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ES2121193T3 (es) Derivados de bencimidazoles.
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
TR199701534T1 (xx) 1,2,4-triazol t�revlerinin, kanserlerin tedavisi i�in bir ila� �retilmesinde kullan�m�.
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
TR200101633T2 (tr) Farmasötik bileşim
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
TR199801289T2 (en) Terap�tik bile�ikler.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE342734T1 (de) Adenosin a1 antagonisten gegen männliche sterilität
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.